bpc 157 what is it benefits risks research Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing BPC-157: What It Is, What

Because BPC-157 lacks robust human safety data across the proposed routes of administration, the FDA states it does not have enough information to know whether compounded BPC-157 would cause harm in humans

Here is the realistic breakdown of what happens when you introduce BPC-157 to an injury, written from the perspective of watching hundreds of athletes and patients get back in the game

Injectable peptides from licensed compounding pharmacies are sterile and properly dosed

A 2025 systematic review in Orthopaedic Sports Medicine analyzed 36 studies on BPC-157 and found that the peptide improved functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bone injury models